Literature DB >> 22385135

The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation.

Dusan Sokolovic1, Jelenka Nikolic, Gordana Kocic, Tatjana Jevtovic-Stoimenov, Andrej Veljkovic, Miroslav Stojanovic, Zoran Stanojkovic, Danka M Sokolovic, Marija Jelic.   

Abstract

Accumulation of hydrophobic bile acids (BAs) during cholestasis plays an important role in apoptosis initiation as well as oxidative stress increase in liver cells. Ursodeoxycholic acid (UDCA) acts as a protector in BA-induced cell injury.The aim of the study was to evaluate the effect of UDCA on oxidative stress level and DNase I and II activity caused by liver injury in bile duct ligation (BDL) rats.Wistar rats were divided in four groups: group 1, control (sham-operated); group 2, sham-operated and injected with UDCA (30 mg/kg); group 3,animals with BDL; and group 4,UDCA-treatedcholestatic rats. Animals were sacrificed after 9 days. Malondialdehyde (MDA; lipid peroxidation end-product) level and protein-molecule oxidative modification (carbonyl group content) significantly increased in BDL rat liver. Catalase (CAT) activity in liver tissue was found to be decreased in BDL rats. In addition, xanthine oxidase (XO) activity, which is thought to be one of the key enzymes producing reactive oxygen species, was found to be increased in the cholestatic group. The apoptotic effect in cholestasis was probably triggered by the increased activation of DNase I and II. The protective effect of UDCA on liver tissue damage in BDL rats, in comparison to cholestatic liver, were 1) decrease of MDA levels, 2) increased CAT activity, 3) reduced XO activity, and 4) effect on terminal apoptotic reaction, shown as a decrease in DNase I and II activity.Therefore, UDCA may be useful in the preservation of liver function in cholestasis treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22385135     DOI: 10.3109/01480545.2012.658919

Source DB:  PubMed          Journal:  Drug Chem Toxicol        ISSN: 0148-0545            Impact factor:   3.356


  10 in total

Review 1.  The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review.

Authors:  Zun Xiang; Yi-peng Chen; Kui-fen Ma; Yue-fang Ye; Lin Zheng; Yi-da Yang; You-ming Li; Xi Jin
Journal:  BMC Gastroenterol       Date:  2013-09-23       Impact factor: 3.067

2.  Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice.

Authors:  Ja Kyung Kim; Kwan Sik Lee; Hye Young Chang; Woon Kyu Lee; Jung Il Lee
Journal:  J Transl Med       Date:  2014-07-01       Impact factor: 5.531

3.  Anti-fibrotic effect of Holothuria arenicola extract against bile duct ligation in rats.

Authors:  Sohair R Fahmy
Journal:  BMC Complement Altern Med       Date:  2015-02-05       Impact factor: 3.659

4.  In vivo study of hepatic oxidative stress and mitochondrial function in rabbits with severe hypotension after propofol prolonged infusion.

Authors:  Sónia Campos; Luís Félix; Carlos Venâncio; Maria de Lurdes Pinto; Francisco Peixoto; Paula Guedes de Pinho; Luís Antunes
Journal:  Springerplus       Date:  2016-08-15

5.  Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes.

Authors:  Wenxi He; Yanjiao Xu; Chengliang Zhang; Jingli Lu; Juan Li; Dong Xiang; Jinyu Yang; Mujun Chang; Dong Liu
Journal:  Drug Des Devel Ther       Date:  2017-12-05       Impact factor: 4.162

6.  Integrating Network Analysis and Metabolomics to Reveal Mechanism of Huaganjian Decoction in Treatment of Cholestatic Hepatic Injury.

Authors:  Qin Dong; Jiao Chen; Yan-Ping Jiang; Zong-Ping Zhu; Yong-Feng Zheng; Jin-Ming Zhang; Zhen Zhang; Wen-Qing Chen; Shi-Yi Sun; Lan Pang; Xin Yan; Wan Liao; Chao-Mei Fu
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810

7.  Biomarkers and Mechanism Analysis for Polygoni Multiflori Radix Preparata-Induced Liver Injury by UHPLC-Q-TOF-MS-Based Metabolomics.

Authors:  Liming Wang; Zhida Wang; Yanchao Xing; Erwei Liu; Xiumei Gao; Linlin Wang; Zhifei Fu
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-23       Impact factor: 2.629

8.  Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.

Authors:  Amr A A Mahmoud; Shimaa M Elshazly
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

9.  An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients.

Authors:  Pathik Parikh; Meghraj Ingle; Jatin Patel; Prasad Bhate; Vikas Pandey; Prabha Sawant
Journal:  Saudi J Gastroenterol       Date:  2016 May-Jun       Impact factor: 2.485

Review 10.  Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart.

Authors:  Noorul Izzati Hanafi; Anis Syamimi Mohamed; Siti Hamimah Sheikh Abdul Kadir; Mohd Hafiz Dzarfan Othman
Journal:  Biomolecules       Date:  2018-11-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.